GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Cronos Group Inc (TSX:CRON) » Definitions » Institutional Ownership

Cronos Group (TSX:CRON) Institutional Ownership : 7.79% (As of May. 22, 2024)


View and export this data going back to 2014. Start your Free Trial

What is Cronos Group Institutional Ownership?

Institutional ownership is the percentage of shares that are owned by institutions out of the total shares outstanding. As of today, Cronos Group's institutional ownership is 7.79%.

Insider Ownership is the percentage of shares that are owned by company insiders relative to the total shares outstanding. As of today, Cronos Group's Insider Ownership is 0.00%.

Float Percentage Of Total Shares Outstanding is the percentage of float shares relative to the total shares outstanding. As of today, Cronos Group's Float Percentage Of Total Shares Outstanding is 52.39%.


Cronos Group Institutional Ownership Historical Data

The historical data trend for Cronos Group's Institutional Ownership can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Cronos Group Institutional Ownership Chart

Cronos Group Historical Data

The historical data trend for Cronos Group can be seen below:

2023-07-31 2023-08-31 2023-09-30 2023-10-31 2023-11-30 2023-12-31 2024-01-31 2024-02-29 2024-03-31 2024-04-30
Institutional Ownership 7.72 8.17 8.41 8.45 7.59 7.53 7.50 7.83 7.87 7.79

Cronos Group Institutional Ownership Calculation

The percentage of shares that are owned by institutions out of the total shares outstanding.


Cronos Group (TSX:CRON) Business Description

Traded in Other Exchanges
Address
111 Peter Street, Suite 300, Toronto, ON, CAN, M5V 2H1
Cronos Group, headquartered in Toronto, Canada cultivates and sells medicinal and recreational cannabis through its medicinal brand, Peace Naturals, and its two recreational brands, Cove and Spinach. Although it primarily operates in Canada, Cronos exports medical cannabis primarily to Israel. In the U.S. the company has an option to acquire 10.5% of U.S. multistate operator PharmaCann upon easing of federal prohibition.
Executives
Michael Ernest Coates Director